1,3-dipropyl-8-cyclopentylxanthine has been researched along with nitrites in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albino-Teixeira, A; Carvalho, F; Fernandes, E; Laranjinha, J; Morato, M; Nunes, C; Pinho, D; Sousa, T | 1 |
Chen, S; Dong, H; Hou, L; Hu, S; Wang, S; Xiong, L; Zhang, H; Zhang, J | 1 |
2 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and nitrites
Article | Year |
---|---|
Scavenging of nitric oxide by an antagonist of adenosine receptors.
Topics: Adenosine A2 Receptor Antagonists; Animals; Caffeine; Dose-Response Relationship, Drug; Free Radical Scavengers; Male; Nitrates; Nitric Oxide; Nitrites; Rats; Rats, Wistar; Receptor, Adenosine A1; Xanthines | 2005 |
Noninvasive limb remote ischemic preconditioning contributes neuroprotective effects via activation of adenosine A1 receptor and redox status after transient focal cerebral ischemia in rats.
Topics: Adenosine; Analysis of Variance; Animals; Brain Infarction; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Extremities; Glutathione; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Ischemic Preconditioning; Lipid Peroxidation; Male; Nervous System Diseases; Neuroprotective Agents; Nitrites; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Severity of Illness Index; Superoxide Dismutase; Tumor Necrosis Factor-alpha; Xanthines | 2012 |